Another discovery using TCGADEPMAP was the prediction of PAPSS1 synthetic lethality with deletion of PAPSS2 and the neighboring tumor suppressor, PTEN, which were frequently co-deleted in TCGA patient tumors (43% co-incidence) yet were largely unaffected in cancer cell lines (Extended Data Fig. 4a–g). The gene discussed is PAPSS2; the disease is cancer.